Human Parainfluenza Viruses Diagnostic Market Size, Share, Growth, And Industry Analysis, By Type (HPV Testing, Follow-up HPV Testing, Co-testing, and Human Parainfluenza Viruses Diagnostics), By Application (Diagnostic Centers, Hospitals and Clinic), Regional Insights, and Forecast To 2031

Updated On: 01 April 2024

Human Parainfluenza Viruses Diagnostic Market Report Overview

• 

• Request a Free Sample to learn more about this report

The global human parainfluenza viruses diagnostics market size was USD 580 million in 2022 and to touch USD 1189 million in 2031, at a CAGR of 8.3% from 2022 to 2031.

Human respiratory illnesses are brought on by a family of four viruses called human parainfluenza viruses. These viruses cause a variety of symptoms, from minor infections like the common cold to more serious ones like pneumonia. Because different strains of the human parainfluenza virus may respond differently to treatment, accurate diagnosis of illness is crucial. The human parainfluenza virus (HPIV) is the second most common reason for paediatric hospitalisation and typically causes respiratory illness in new-borns and young children under the age of five. The most dangerous human parainfluenza viruses, known as HPIV-1 and HPIV-3, are a series of four single-stranded RNA viruses named HPIV 1-4.

The respiratory tract's tiny airways' lining is damaged by the virus. A variety of laboratory assays are available to identify the HPIV virus in patient respiratory samples. Cell culture utilising samples from serological and nasal swab tests is the technique that is most frequently utilised. Young children might have their chest x-rayed to monitor disease progression.

COVID-19 Impact: Pandemic Hamper the Demand of Human Parainfluenza Viruses Diagnostics to Market Growth

COVID-19 has been a key market growth restraint because of several factors, including end-user operating cost reductions and disruptions in the supply of spare parts as a result of slow manufacturing activity and logistical difficulties. Battery providers have taken further steps to ensure the quality of their services for clients who have signed long-term contracts with them. Vendors are using digital tools and following the preventative guidelines, which include social distance guidelines and the use of protective kits in case end users occasionally need on-site inspection and repair services.

Latest Trends

"Demand for Research into Influenza Diagnostics is Expanded to Boost Market Growth"

Research and development activities have risen in response to the increasing prevalence of human parainfluenza virus diagnoses around the world. Most of the research work focuses on creating quicker and more precise diagnostic treatments for human parainfluenza viruses, which will spur market expansion. The Collaborative Influenza Vaccine Innovation Centers (CIVICS) programme was started by the US NIH's National Institute of Allergy and Infectious Diseases (NIAID) to fund a wide range of influenza research initiatives.

Human Parainfluenza Viruses Diagnostic Market Segmentation

• 

• Request a Free Sample to learn more about this report

• By Type Analysis

According to type, the human parainfluenza viruses diagnostics market can be segmented into HPV Testing, Follow-up HPV Testing, Co-testing, Human Parainfluenza Viruses Diagnostics.

In terms of type, the HPV Testing is anticipated to be the largest segment during the forecast period.  

• By Application Analysis

Based on application, the human parainfluenza viruses diagnostics market can be divided into Diagnostic Centers, Hospitals and Clinic.

In terms of application, Diagnostic Centers market is projected to hold the largest market share through 2031.

Driving Factors

"Early Influenza Diagnosis Awareness to Drive Market Growth  "

An early diagnosis of influenza results in better care and treatment. Early diagnosis enables both patients and medical professionals to handle and support several critical medical decisions. After the neurological signals connected to a certain medical illness are discovered, having a proper and early diagnosis has many advantages. One of the best and most often used methods for identifying numerous infectious disorders connected to bacterial, viral, or protozoal infections is laboratory testing. A wide variety of infectious disorders are detected via immunoassays, biochemical characterisation, polymerase chain reaction, isothermal nucleic acid amplification tests, and next-generation sequencing. 

"Technological Improvements in Genomics and Proteomics Which Led to Heightened Market Growth "

A significant quantity of data was produced by the Human Genome Project and developments in molecular and biomedical technologies, which led to the creation of numerous assays and technologies helpful for the diagnosis and treatment of influenza infections. These new genomic and proteomic technologies, like PCR-based and microarray-based detection, aid in the identification of novel influenza viruses. Additionally, they allow for quicker and better surveillance of infectious diseases, which presents a business opportunity.

Restraining Factors

"Sensitivity and Specificity of Test Variations by a Diagnostics is Decreasing market Demand"

 The major variables that affect the outcomes of influenza diagnostic tests are sensitivity and specificity. The complexity of these tests is mostly due to the antigenic diversity of influenza viruses. As a result, there are variations in the sensitivity and specificity of diagnostic tests for human parainfluenza viruses which influence the final test results. This is a significant problem limiting the growth of the market for influenza diagnostics because false-negative results are more frequent than false-positive ones, especially during the height of influenza season. Recently, the FDA approved fast diagnostics for influenza (RIDTS)  

Human Parainfluenza Viruses Diagnostic Market Regional Insights

• 

• Request a Free Sample to learn more about this report

"The North America Region is Dominating Market Due to Developed Healthcare System"

In terms of revenue share, North America dominated the global human parainfluenza viruses diagnostics market in some regions. This is a result of a developed healthcare system, high awareness levels and relatively high healthcare spending, as well as prevalence rates for diseases linked to HPV. Over the course of the projection period, rising government initiatives and programs are also anticipated to fuel regional growth. This is a result of rising awareness and higher than average incidence rates in this region for diseases linked to HPV. Additionally, widespread use of HPV testing in healthcare settings, as well as an increase in government campaigns and programs to encourage HPV vaccination among teenagers.

Key Industry Players

"Adoption Experiential Marketing Services by Key Players Influencing Market Development"

The top key players in the market are Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene. Most of the top players hold human parainfluenza viruses diagnostics market share in some regions. In addition, the strategies to develop new technologies, capital investment in R&D, improve product quality, acquisitions, mergers, and compete for the human parainfluenza viruses diagnostics market growth in the competition help them to perpetuate their position and value in the market. Besides, collaboration with other companies & extensive possession of market shares by the key players stimulates the human parainfluenza viruses diagnostics market. 

List of Market Players Profiled

• Qiagen (Germany)
• Roche Diagnostics (Switzerland)
• Hologic (U.S.)
• Abbott Laboratories (U.S.)
• BD (U.S.)
• Seegene (South Korea)

Report Coverage

This report examines an understanding of the human parainfluenza viruses diagnostics market’s size, share, growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.

Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.

This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.